Synopsys Shines Brighter: Elliott's Bet Validates a Tech Powerhouse

Geojit Financial Services Sees Bright Prospects: Why Tata Elxsi Is Catching Analysts' Eyes

GE Vernova's Energized Outlook: Rothschild & Co. Delivers a Double Upgrade to 'Buy'

Why AECOM's Stellar Earnings Just Solidified Its 'Buy' Status

Greenply Industries: Why Choice Equities Sees Bright Prospects Ahead

Jim Cramer's Enthusiastic Endorsement: Medline Deemed "Unbelievable" and a Strong "Buy"

CAVA Group: Why One Analyst Sees Major Outperformance Ahead

A Nuanced View: Why Goldman Sachs Sees Beyond the Bearishness for Eternal Shares

India's Ascendant Star: Why This High-Growth ETF Just Earned a Buy Rating

Marvell's AI Play Gets a Big Thumbs Up

Hero MotoCorp: Why Nirmal Bang is Bullish on This Two-Wheeler Giant

Unlocking Potential: Why One Health Tech Stock Could Surge 50%

Vishnu Chemicals: Why Analysts See Bright Prospects and Significant Upside

A Fresh Look at Regeneron: Why Analysts Are Seeing Significant Upside

The Enduring Saga of Big Blue: IBM's Quiet Ascent in a Volatile Market

Manulife Financial: A Stronger Signal From the Analysts

A Fresh Look at the Parks: Mizuho Sees More Upside for United Parks & Resorts

The Sonos Sound: Why One Analyst Hears a Symphony of Growth

The Energy Pipeline You Might Be Missing: Why DT Midstream's Growth Story Is Catching Eyes

Parsons Corp: More Than Just Concrete and Code – Why This Giant Still Demands Attention

The Electric Shift: Why Tata Power Is Charging Ahead (And What Analysts Are Saying)

Deutsche Bank Unleashes Bullish 'Buy' Rating on AppLovin, Targeting $60 Amidst E-commerce Ad-Tech Surge

Unpacking Wall Street's Latest Insights: Your Monday Stock Playbook

Federal Bank's Stellar Q2 Performance Ignites Market Enthusiasm, Shares Soar 8%

Eaton Corporation: Powering the Future with Unstoppable Growth and Cash Flow Excellence

Amara Raja Soars: Nuvama Reaffirms 'Buy' on New Energy Vision Post CFO Meeting

Glaukos Soars as Goldman Sachs Crowns it a 'Buy' with Ambitious $100 Price Target

Beyond the Hype: Why Warby Parker Is a Clear Buy Opportunity

Truist Ignites Excitement for Rapport Therapeutics (RAPP) with New 'Buy' Rating and $21 Price Target

Titan International: Why a Recent 'Buy' Upgrade Misses the Mark Amidst Headwinds

Unlocking Value: Why Analysts are Bullish on CESC with a Rs 195 Target!

Melius Stays Bullish on Oracle: A Deep Dive into Its Revenue Growth Story

Truist Ignites Excitement: Janux Therapeutics Stock Receives Bold 'Buy' Rating on Promising H2 Catalysts

Max Healthcare Soars: Nuvama Recommends 'Buy' with Ambitious Rs 970 Target Price!

Ellenbarrie Industrial Gases Ignites Growth: Ambitious Expansion Fuels a 'Buy' Rating from Motilal Oswal

Tech Mahindra Shares Ignite: Nuvama's 'Buy' Rating Fuels Optimism on Deal Wins and Margin Growth

Navigating the Path to Approval: Why REGENXBIO (RGNX) Remains a Strong Investment with RGX-121 for Hunter Syndrome

ICICI Bank Set to Soar: Emkay Global Bullish on Banking Giant with Rs 1700 Target!

Divi's Labs Soars as Jefferies Upgrades to 'Buy' Amid Strong Outlook and Q4 Performance